NNIT's nominal share capital is DKK 250,000,000 divided into 25,000,000 shares with a nominal value of DKK 10 each.

No shares carry special rights and thus all shares rank pari passu in respect of voting rights, pre-emption rights, redemption and conversion and in respect of eligibility to receive dividends or proceeds in the event of dissolution and liquidation.

All shares are issued and fully paid up.

Each share of a nominal value of DKK 10 gives the holder the right to ten votes at general meetings.

NNIT has not issued any securities that are convertible, exchangeable nor have warrants attached.

The following table outlines the information regarding the NNIT ownership structure.

Major shareholders

In accordance with section 55 of the Danish Companies Act and section 38 in the Danish Capital Markets Act, the following investors have reported holding more than 5 percent of NNIT's share capital or voting rights as of December 31, 2022 :

Novo Holdings A/S 33.50%
Novo Nordisk A/S 17.50%
Chr. Augustinus Fabrikker Akst. 5.86%
Danske Bank A/S5.12% 

Novo Holdings A/S has 51 percent indirect ownership through its holding of Novo Nordisk A/S.

IR Contact

Carsten Ringius

Chief Financial Officer

+45 3077 8888